Table 2.
Top performing GLMMs that partitioned variance in the composition of the bacteriome among different hypothetical groupings of the Site 1 and Site 2 filtration regimens.
| Fixed effects | Random effects | Hypothesis |
|---|---|---|
| Offset(log(sum)), mosquito-stage, treatment2, mosquito-stage*treatment2 | ASV, mesocosm, ASV*mosquito-stage, ASV*mesocosm, ASV*treatment, ASV*mosquito-stage*treatment2 | Mosquito bacteriome assembly is modulated by the inclusion of large microbial cells in the inoculate. Treatment2 groups filtrations into individual groups: lab, 0.1 μm, 10 μm, and 30–50 μm. |
| Offset(log(sum)), mosquito-stage, BacSource3, mosquito-stage*BacSource3 | ASV, mesocosm, ASV*BacSource3, ASV*mesocosm, ASV*BacSource3, ASV*mosquito-stage*BacSource3 | Mosquito bacteriome assembly is not modulated by the inclusion of large microbial cells in the environment but is modulated by bacteria source (natural environment versus lab environment). |
| Offset(log(sum)), mosquito-stage, treatment, mosquito-stage*treatment | ASV, mesocosm, ASV*mosquito-stage, ASV*mesocosm, ASV*treatment, ASV*mosquito-stage*treatment | Mosquito bacteriome assembly is modulated by the inclusion of larger microbial cells in the inoculate. Treatment groups filtrations into individual modules: lab (replicate 1), lab (replicate 2), lab (replicate 3), 0.1 μm, 10 μm, and 30–50 μm. |